BioSpace News Archive

Eisai Inc. announced today the Company will present findings from its robust neurology portfolio, including data from the Phase 3 Clarity AD trial for LEQEMBI ® .

Portage Biotech Inc. today reported that it is expanding its evaluation of strategic alternatives and implementing additional measures to extend its available cash runway.

TheracosBio today announced the publication of a study titled “Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus.

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced it has received approval of its divestment plan for GRAIL from the European Commission.

American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a pioneer in cutting-edge technology designed to protect against electromagnetic

Company remains focused on launching afami-cel later this year with a PDUFA date of August 4th and developing its broader sarcoma franchise

Evolus, Inc., a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, reported the grant of non-qualified stock options to purchase an aggregate of 9,651 shares of Evolus and an aggregate of 20,971 restricted stock units of the company’s common stock to 10 newly hired non-executive employees of the company.

According to Nova One Advisor, the U.S. gene therapy market size was valued at USD 3.19 billion in 2023

According to Nova One Advisor, the global computational biology market size was valued at USD 6.10 billion in 2023 and is projected to reach USD 21.04 billion by 2033, registering a CAGR of 13.18% from 2024 to 2033.

According to Nova One Advisor, the U.S. Biotechnology market size was estimated at USD 552.49 billion in 2023